v3.26.3
Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Loss $ (2,900) $ (11,255)
Adjustments to reconcile loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 23 26
Financing expenses, net 69 9,894
Theoretical wages to an interested party 26 28
Share-based compensation expense 284 467
Adjustments to profit or loss items 402 10,415
Changes in assets and liabilities:    
Decrease in prepaid expenses and other accounts receivable 247 79
Increase (decrease) in trade payables (228) 104
Increase (decrease) in accounts payable (393) 55
Changes in assets and liabilities (374) 238
Net cash provided by (used in) operating activities (2,872) (602)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities
Cash flows from financing activities:    
Issue of share capital and warrants (net of issuance costs) 1,350
Proceeds of exercise of warrants 16
Receipt of a loan from interested parties 278
Net cash provided by financing activities 1,366 278
Exchange rate differences on balances of cash, cash equivalents and restricted cash 15 (27)
Decrease in cash and cash equivalents (1,491) (351)
Cash and cash equivalents at the beginning of the period 2,201 650
Cash and cash equivalents at the end of the period 710 299
Supplemental disclosure of non-cash activities:    
Deemed dividend 2,688
Conversion of shareholder loan into equity $ 4,401